Juniper Pharma (JNP) Tops Q3 EPS by 14c

Juniper Pharma (NASDAQ: JNP) reported Q3 EPS of $0.09, $0.14 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $11.5 million versus the consensus estimate of $7.1 million.

For earnings history and earnings-related data on Juniper Pharma (JNP) click here.

You May Also Be Interested In

• Ackman adds Netflix, Visa and Mastercard in portfolio revamp
• Bending Spoons S.p.A. (BSP) Tops Q2 EPS by 19c; offers guidance
• Stratasys (SSYS) Tops Q2 EPS by 2c ;; Offers Guidance